NAC, the GSH precursor, has provided beneficial effects in combating AD pathology through high cytoplasmic cytochrome c release, reduced mitochondrial membrane potential, and reduced Bcl-2 expression, p53 expression and caspase pathways. The gene discussed is CYCS; the disease is Alzheimer disease.